Ryan Grover
About Ryan Grover
Ryan Grover is the Chief of Head & Neck, Sarcoma, Gyn, and CNS Proton Therapy at Scripps Proton Therapy Center and a Voluntary Clinical Assistant Professor at the University of California, San Diego - School of Medicine.
Current Roles at Scripps Health
Ryan Grover currently holds the position of Chief of Head & Neck, Sarcoma, Gyn, and CNS Proton Therapy at the Scripps Proton Therapy Center in Greater San Diego Area. In this role, he focuses on the clinical application and optimization of proton radiotherapy for various cancers, including head and neck, sarcoma, gynecological, and central nervous system cancers.
Affiliation with University of California, San Diego
Ryan Grover serves as a Voluntary Clinical Assistant Professor at the University of California, San Diego - School of Medicine. Since starting this role in May 2014, he has contributed to the academic environment by sharing his knowledge and expertise in proton radiotherapy with medical students and residents.
Past Experience at Loma Linda University Medical Center
Ryan Grover's tenure at Loma Linda University Medical Center included roles as an Assistant Professor and Chief of Head and Neck Radiation Oncology from 2006 to 2012. Prior to that, he completed a residency in radiation oncology from 2002 to 2006, following a preliminary year in internal medicine at UC Irvine Medical Center from 2001 to 2002.
Educational Background
Ryan Grover earned his MD from the Keck School of Medicine of the University of Southern California, where he studied from 1997 to 2001. Before that, he obtained a Bachelor of Arts in Psychobiology with Honors from Claremont McKenna College, completing his studies in 1997. His education laid a strong foundation for his career in medical and radiation oncology.
Research and Clinical Interests
Ryan Grover has been involved in proton-beam radiotherapy since 2002. His research focuses on the clinical application and optimization of proton radiotherapy, particularly for head and neck and central nervous system cancers. This specialization helps advance the effectiveness and precision of cancer treatments.